Development and evaluation of liposomal formulation containing nimodipine on anxiolytic activity in mice

Pharmacology Biochemistry and Behavior

Volumn 116, Issue , 2014, Pages 64-68

  Moreno, Lina Clara Gayoso E Almendra Ibiapina ^a,b   Da Silva Oliveira, Giselle Zayra ^a   Cavalcanti, Isabella Macário Ferro ^b   Santos Magalhães, Nereide Stela ^b   Rolim, Hercília Maria Lins ^a   De Freitas, Rivelilson Mendes ^a  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Anxiolytic; Liposome; Mice; Nimodipine

Indexed keywords

FLUMAZENIL; LIPOSOME; NIMODIPINE; ANXIOLYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; GROOMING; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; REARING; TRANQUILIZING ACTIVITY; ANIMAL; MALE;

ANIMALIA; MUS; RODENTIA;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; CALCIUM CHANNEL BLOCKERS; LIPOSOMES; MALE; MICE; NIMODIPINE;

EID: 84890043805     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.10.023     Document Type: Article

References (32)

1. J. Archer Tests for emotionality in rats and mice. A review Anim Behav 21 1973 205 235
2. A. Aslan, M. Gurelik, M. Cemek, H.M. Goksel, and M.E. Buyukokuroglu Nimodipine can improve cerebral metabolism and outcome in patients with severe head trauma Pharmacol Res 59 2009 120 124
3. C.A. Bartley, M. Hay, and M.H. Bloch Meta-analysis: aerobic exercise for the treatment of anxiety disorders Prog Neuropsychopharmacol Biol Psychiatry 45 2013 34 39
4. M. Casarrubea, V. Roy, F. Sorbera, M.S. Magnusson, A. Santangelo, and A. Arabo Temporal structure of the rat's behavior in elevated plus maze test Behav Brain Res 237 2013 290 299
5. S.S. Chalikwar, V.S. Belgamwar, V.R. Talele, S.J. Surana, and M.U. Patil Formulation and evaluation of nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system Colloids Surf B 97 2012 109 116
6. J.N. Crawley Exploratory behavior models of anxiety in mice Neurosci Biobehav Rev 9 1985 37 44 (Pubitemid 15136669)
7. J. Divljakovi'c, M. Mili'c, O.A. Namjoshi, V.V. Tiruveedhula, T. Timi'c, and J.M. Cook βCCT, an antagonist selective for α(1)GABA(A) receptors, reverses diazepam withdrawal-induced anxiety in rats Brain Res Bull 91 2013 1 7
8. T. Enkel, M. Thomas, and D. Bartsch Differential effects of subchronic phencyclidine on anxiety in the light-enhanced startle-, light/dark exploration- and open field tests Behav Brain Res 263 2013 61 65
9. M.A. Frye, P.J. Pazzaglia, M.S. George, D.A. Luckenbaugh, E. Vanderham, and C.L. Davis Low CSF somatostatin associated with response to nimodipine in patients with affective illness Biol Psychiatry 53 2003 180 183 (Pubitemid 36126482)
10. P.M. Galdino, M.V.M. Nascimento, I.F. Florentino, F.C. Lino, J.O. Fajemiroye, and B.A. Chaibub The anxiolytic-like effect of an essential oil derived from Spiranthera odoratissima A. St. Hil. leaves and its major component, β-caryophyllene, in male mice Prog Neuropsychopharmacol Biol Psychiatry 38 2012 276 284
11. H.I. Kaplan, and B.J. Sadock Comprehensive textbook of psychiatry 2005 Lippincot Williams & Wilkins Baltimore, MD
12. N. Kumar, N. Singh, and A.S. Jaggi Anti-stress effects of cilnidipine and nimodipine in immobilization subjected mice Physiol Behav 150 2012 1148 1155
13. V. Kumar, Z.A. Bhat, and D. Kumar Animal models of anxiety: a comprehensive review J Pharmacol Toxicol Methods 68 2013 175 183
14. M.C.B. Lira, M.P. Siqueira-Moura, H.M.L. Rolim-Santos, F.C.S. Galetti, A.R. Simioni, and N.P. Santos In vitro uptake and antimycobacterial activity of liposomal usnic acid formulation J Liposome Res 19 2009 49 58
15. R.G. Lister The use of a plus-maze to measure anxiety in the mouse Psychopharmacology (Berl) 92 1987 180 185 (Pubitemid 17072893)
16. D.J. Maack, M.T. Tull, and K.L. Gratz Examining the incremental contribution of behavioral inhibition to generalized anxiety disorder relative to other Axis I disorders and cognitive-emotional vulnerabilities J Anxiety Disord 26 2012 689 695
17. K. Maigaard, I. Hageman, A. Jørgensen, M.B. Jørgensen, and G. Wörtwein Electroconvulsive stimulations prevent chronic stress-induced increases in l-type calcium channel mRNAs in the hippocampus and basolateral amygdala Neurosci Lett 516 2012 24 28
18. M.M.F. Marinho, V.M.S. Bruin, F.C.F. Souza, L.M.V. Aguiar, R.S.N. Pinho, and G.B.S. Viana Inhibitory action of a calcium channel blocker (nimodipine) on seizures and brain damage induced by pilocarpina and lithium-pilocarpine in rats Neurosci Lett 235 1997 13 16 (Pubitemid 27471093)
19. M.A. Mikati, G.L. Holmes, S. Werner, N. Bakkar, L. Carmant, and Z. Liu Effects of nimodipine on the behavioral sequelae of experimental status epilepticus in prepubescent rats Epilepsy Behav 5 2004 168 174 (Pubitemid 38461206)
20. P. N'Gouemo Probing the role of the sodium/calcium exchanger in pentylenetetrazole-induced generalized seizures in rats Brain Res Bull 90 2013 52 57
21. V.S. Nascimento, M.S. D'alva, A.A. Oliveira, R.M. Freitas, S.M.M. Vasconcelos, and F.C.F. Sousa Antioxidant effect of nimodipine in young rats after pilocarpine-induced seizures Pharmacol Biochem Behav 82 2005 11 16 (Pubitemid 41423481)
22. P.J. Pazzaglia, M.S. George, R.M. Post, R.D. Rubinow, and C.L. Davis Nimodipine increases CSF somatostatin in affectively ill patients Neuropsychopharmacology 13 1995 75 83
23. G. Quaglio, C. Pattaro, G. Gerra, S. Mathewson, P. Verbanck, and D.C.D. Jarlais High dose benzodiazepine dependence: description of 29 patients treated with flumazenil infusion and stabilised with clonazepam Psychiatry Res 198 2012 457 462
24. I.M. Raupp, A. Sereniki, S. Virtuoso, C. Ghislandi, E. Cavalcanti, and E.L. Silva Anxiolytic-like effect of chronic treatment with Erythrina velutina extract in the elevated plus-maze test J Ethnopharmacol 118 2008 295 299
25. 2 challenge J Anxiety Disord 24 2010 423 432
26. A.R. Salomons, T. Kortleve, N.R. Reinders, S. Kirchhoff, S.S. Arndt, and F. Ohl Susceptibility of a potential animal model for pathological anxiety to chronic mild stress Behav Brain Res 209 2010 241 248
27. N.S. Santos-Magalhães, and V.C.F. Mosqueira Nanotechnology applied to the treatment of malaria Adv Drug Deliv Rev 62 2010 560 575
28. F.C.F. Sousa, C.T.V. Melo, C.O.M. Citó, F.H.C. Félix, S.M.M. Vasconcelos, and M.M.F. Fonteles Plantas medicinais e seus constituintes bioativos: Uma revisão da bioatividade e potenciais benefícios nos distúrbios da ansiedade em modelos animais Rev Bras Farmacogn 18 2008 642 654
29. C. Sun, J. Wang, J. Liu, L. Qiu, W. Zhang, and L. Zhang Liquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokinetics AAPS PharmSciTech 14 2013 332 338
30. H.L. Wong, X.Y. Wu, and R. Bendayan Nanotechnological advances for the delivery of CNS therapeutics Adv Drug Deliv Rev 64 2012 686 700
31. S.U. Yanpallewar, D. Hota, R. Rai, M. Kumar, and S.B. Acharya Nimodipine attenuates biochemical, behavioral and histopathological alterations induced by acute transient and long-term bilateral common carotid occlusion in rats Pharmacol Res 49 2004 143 150 (Pubitemid 37485710)
32. J.B. Zou, B.F. Dear, N. Titov, C.N. Lorian, L. Johnston, and J. Spence Brief internet-delivered cognitive behavioral therapy for anxiety in older adults: a feasibility trial J Anxiety Disord 26 2012 650 655